I think the primary focus of our strategy implementation team is to ramp up capacity in Canada. You're right that the manufacturing process is complex, and it varies based on vaccine type. We're trying to build up capacities to not only support the Canadian population but also to eventually become a global player that can support and partner with other countries as we build out our strategy.
However, we're starting from a place where the capacity is lacking in Canada, so the first step is to make the investments to build up the industry to be able to support moving forward.